CKB Inhibits Epithelial-Mesenchymal Transition and Prostate Cancer Progression by Sequestering and Inhibiting AKT Activation

Scientists discovered that brain-type creatine kinase (CKB) was a negative regulator of epithelial-mesenchymal transition and AKT activation, which revealed a new mode of their regulation.